The members of the Roivant Discovery scientific advisory board (SAB) are world-leading experts in quantum physics, computational drug development, parallel computing, biology and chemistry. Our SAB also includes clinicians whose insights into the needs of patients help guide the development of a new scientific paradigm and delivery of novel medicines for patients in need.
